Michael Campbell to Humans
This is a "connection" page, showing publications Michael Campbell has written about Humans.
Connection Strength
0.411
-
Woods AL, Li Y, Keegan TH, Nu?o M, Graves CE, Campbell MJ. Incidence and Characteristics of Patients Readmitted for Hypoparathyroidism After Thyroidectomy for Differentiated Thyroid Cancer in California. World J Surg. 2025 Aug; 49(8):2187-2194.
Score: 0.034
-
Woods AL, Li Y, Keegan TH, Nu?o M, Graves CE, Campbell MJ. Hypoparathyroidism After Total Thyroidectomy: A Population-Based Analysis of California Databases. J Surg Res. 2025 06; 310:268-274.
Score: 0.034
-
Campbell MJ, Wolf DM, Yau C, Brown-Swigart L, Wulfkuhle J, Gallagher IR, Zhu Z, Bolen J, Vandenberg S, Hoyt C, Mori H, Borowsky A, Sit L, Perlmutter J, Asare SM, Nanda R, Liu MC, Yee D, DeMichele AM, Hylton NM, Pusztai L, Berry DA, Hirst GL, Petricoin EF, Veer LV, Esserman L. Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer. Cell Rep Med. 2024 Nov 19; 5(11):101799.
Score: 0.033
-
Corwin MT, Kadivar SC, Graves CE, Kamangar E, Carney BW, Campbell MJ. CT of hemorrhagic adrenal adenomas: radiologic-pathologic correlation. Abdom Radiol (NY). 2023 02; 48(2):680-687.
Score: 0.029
-
Graves CE, Campbell MJ. Best Left to the Experts: Proficiency and Experience are Key for Safety in Remote-Access Thyroidectomy for Graves' Disease. World J Surg. 2022 05; 46(5):1114-1115.
Score: 0.027
-
Campbell MJ, Graves CE. The adrenal incidentaloma: An opportunity for surgeons to improve patient care. Am J Surg. 2022 02; 223(2):229-230.
Score: 0.026
-
Mori H, Bolen J, Schuetter L, Massion P, Hoyt CC, VandenBerg S, Esserman L, Borowsky AD, Campbell MJ. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence. J Mammary Gland Biol Neoplasia. 2020 12; 25(4):417-432.
Score: 0.025
-
Mansournia MA, Collins GS, Nielsen RO, Nazemipour M, Jewell NP, Altman DG, Campbell MJ. A CHecklist for statistical Assessment of Medical Papers (the CHAMP statement): explanation and elaboration. Br J Sports Med. 2021 Sep; 55(18):1009-1017.
Score: 0.025
-
Mansournia MA, Collins GS, Nielsen RO, Nazemipour M, Jewell NP, Altman DG, Campbell MJ. CHecklist for statistical Assessment of Medical Papers: the CHAMP statement. Br J Sports Med. 2021 Sep; 55(18):1002-1003.
Score: 0.025
-
Campbell MJ, McCoy KL, Shen WT, Carty SE, Lubitz CC, Moalem J, Nehs M, Holm T, Greenblatt DY, Press D, Feng X, Siperstein AE, Mitmaker E, Benay C, Tabah R, Oltmann SC, Chen H, Sippel RS, Brekke A, Vriens MR, Lodewijk L, Stephen AE, Nagar S, Angelos P, Ghanem M, Prescott JD, Zeiger MA, Aragon Han P, Sturgeon C, Elaraj DM, Nixon IJ, Patel SG, Bayles SW, Heneghan R, Ochieng P, Guerrero MA, Ruan DT. A multi-institutional international study of risk factors for hematoma after thyroidectomy. Surgery. 2013 Dec; 154(6):1283-89; discussion 1289-91.
Score: 0.015
-
Liu NM, Sholevar CJ, Karimzadeh M, Uppuluri J, Van Dongen C, Graves CE, Campbell MJ, Zamora AE, Judge SJ, Canter RJ. The Immune Biology of the Adrenal Gland Microenvironment and Its Role in Metastatic Progression. Int J Mol Sci. 2026 Jan 23; 27(3).
Score: 0.009
-
Kozor R, Schmitt C, Sathanandam S, Merlocco A, Murtaza S, Haque S, Bowers AL, Campbell MJ, Agarwal R, Srivastava M, Pavlov B, Lapp H, Abderrahmane M, Abdellah C, Melas G, Cardoso I, McGrath L, Cemil I, Desai T, Barhate G, Tavri O, Andres KN, Chan F, Clark DE, Lee L, Balfour P, Scothorn B, Nguyen C, Chudgar P, Burkule N, Lakshmivenkateshiah S, Crapanzano OA, Weingarten AJ, Soslow JH, Klusewitz S, Chen M, Kellman P, Hulten E, Bricha OY, Sachs V, Sayad D, Faluk M, Parra D, Surana G, Susar A, Borikar N, Romberg EK, Permut LC, Otto RK, Pillai P, Harrington K, Alsaid A, Gulhane A, Krieger E, Ordovas K, Baritussio A, Bhagirath P, Chen SSM, Dendy JM, Ganigara M, Tunks RD, Johnson JN. Society for Cardiovascular Magnetic Resonance 2024 Cases of SCMR case series. J Cardiovasc Magn Reson. 2026 Summer; 28(1):102695.
Score: 0.009
-
Haddad RI, Bischoff L, Applewhite M, Bernet V, Blomain E, Brito M, Busaidy NL, Campbell M, DeLozier O, Duh QY, Ehya H, Grady E, Guo T, Haymart M, Hunt JP, Kandeel F, Kotwal A, Lamonica DM, Lorch J, Mandel SJ, Markovina S, Mydlarz W, Nabell L, Raeburn CD, Rezaee R, Ridge JA, Ritter H, Roth MY, Salgado SA, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wirth LJ, Wong RJ, Worden F, Yeh MW, Darlow S, Cassara CJ, Sliker B. NCCN Guidelines? Insights: Thyroid Carcinoma, Version 1.2025. J Natl Compr Canc Netw. 2025 07; 23(7).
Score: 0.009
-
Wolf DM, Yau C, Campbell M, Glas A, Barcaru A, Mittempergher L, Kuilman M, Brown-Swigart L, Hirst G, Basu A, Magbanua M, Sayaman R, Huppert L, Delson A, Symmans WF, Borowsky A, Pohlmann P, Rugo H, Clark A, Yee D, DeMichele A, Perlmutter J, Petricoin EF, Chien J, Stringer-Reasor E, Shatsky R, Liu M, Han H, Soliman H, Isaacs C, Nanda R, Hylton N, Pusztai L, Esserman L, van 't Veer L. Immune Subtyping Identifies Patients With Hormone Receptor-Positive Early-Stage Breast Cancer Who Respond to Neoadjuvant Immunotherapy (IO): Results From Five IO Arms of the I-SPY2 Trial. JCO Precis Oncol. 2025 Jun; 9:e2400776.
Score: 0.009
-
Johnson JN, Hoke C, Chamis AL, Campbell MJ, Gearhart A, de Ferranti SD, Beroukhim R, Mozumdar N, Cartoski M, Nees S, Hudson J, Kakhi S, Daryani Y, Pasan Botheju WS, Shah KB, Makkiya M, Dimza M, Moguillansky D, Al-Ani M, Andreae A, Kim H, Ahamed H, Kannan R, Joji CA, Baritussio A, Dendy JM, Bhagirath P, Ganigara M, Hulten E, Tunks R, Kozor R, Chen SSM. Society for Cardiovascular Magnetic Resonance 2023 Cases of SCMR case series. J Cardiovasc Magn Reson. 2024; 26(2):101086.
Score: 0.008
-
Gallagher RI, Wulfkuhle J, Wolf DM, Brown-Swigart L, Yau C, O'Grady N, Basu A, Lu R, Campbell MJ, Magbanua MJ, Copp? JP, Asare SM, Sit L, Matthews JB, Perlmutter J, Hylton N, Liu MC, Symmans WF, Rugo HS, Isaacs C, DeMichele AM, Yee D, Pohlmann PR, Hirst GL, Esserman LJ, van 't Veer LJ, Petricoin EF. Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial. Cell Rep Med. 2023 12 19; 4(12):101312.
Score: 0.008
-
Kyalwazi B, Yau C, Campbell MJ, Yoshimatsu TF, Chien AJ, Wallace AM, Forero-Torres A, Pusztai L, Ellis ED, Albain KS, Blaes AH, Haley BB, Boughey JC, Elias AD, Clark AS, Isaacs CJ, Nanda R, Han HS, Yung RL, Tripathy D, Edmiston KK, Viscusi RK, Northfelt DW, Khan QJ, Asare SM, Wilson A, Hirst GL, Lu R, Symmans WF, Yee D, DeMichele AM, van 't Veer LJ, Esserman LJ, Olopade OI. Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer. JAMA Netw Open. 2023 12 01; 6(12):e2349646.
Score: 0.008
-
Shakir MN, Woods AL, Sun KA, Goldman RE, Campbell MJ, Corwin MT, Graves CE. Incidence, Presentation, and Natural History of Adrenal Hemorrhage: An Institutional Analysis. J Surg Res. 2024 03; 295:53-60.
Score: 0.008
-
Alterio MM, Tobias M, Koehl A, Woods AL, Sun K, Campbell MJ, Graves CE. Who Serves Where: A Geospatial Analysis of Access to Endocrine Surgeons in the United States and Puerto Rico. Surgery. 2024 01; 175(1):32-40.
Score: 0.008
-
Madaniyazi L, Tob?as A, Vicedo-Cabrera AM, Jaakkola JJK, Honda Y, Guo Y, Schwartz J, Zanobetti A, Bell ML, Armstrong B, Campbell MJ, Katsouyanni K, Haines A, Ebi KL, Gasparrini A, Hashizume M. Should We Adjust for Season in Time-Series Studies of the Short-Term Association Between Temperature and Mortality? Epidemiology. 2023 05 01; 34(3):313-318.
Score: 0.007
-
Collins RA, DiGennaro C, Beninato T, Gartland RM, Chaves N, Broekhuis JM, Reddy L, Lee J, Deimiller A, Alterio MM, Campbell MJ, Lee YJ, Khilnani TK, Stewart LA, O'Brien MA, Alvarado MVY, Zheng F, McAneny D, Liou R, McManus C, Dream SY, Wang TS, Yen TW, Alhefdhi A, Finnerty BM, Fahey TJ, Graves CE, Laird AM, Nehs MA, Drake FT, Lee JA, McHenry CR, James BC, Pasieka JL, Kuo JH, Lubitz CC. Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19. Surgery. 2023 Jan; 173(1):93-100.
Score: 0.007
-
Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS, Guo T, Haymart M, Holt S, Hunt JP, Iagaru A, Kandeel F, Lamonica DM, Mandel S, Markovina S, McIver B, Raeburn CD, Rezaee R, Ridge JA, Roth MY, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Yeh M, Cassara CJ, Darlow S. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 08; 20(8):925-951.
Score: 0.007
-
Duncan NS, Campbell MJ, Backos DS, Li C, Rider KC, Stump S, Weaver MJ, Gajewski MP, Beall HD, Reigan P, Natale NR. 10-Alkoxy-anthracenyl-isoxazole analogs have sub-micromolar activity against a Glioblastoma multiforme cell line. Bioorg Med Chem. 2022 09 01; 69:116911.
Score: 0.007
-
Graves CE, Goyal N, Levin A, Nu?o MA, Kim J, Campbell MJ, Shen WT, Gosnell JE, Roman SA, Sosa JA, Duh QY, Suh I. Anxiety During the COVID-19 Pandemic: A Web-Based Survey of Thyroid Cancer Survivors. Endocr Pract. 2022 Apr; 28(4):405-413.
Score: 0.007
-
Johnson JN, Mandell JG, Christopher A, Olivieri LJ, Loke YH, Campbell MJ, Darty S, Kim HW, Clark DE, Frischhertz BP, Fish FA, Bailey AL, Mikolaj MB, Hughes SG, Oneugbu A, Chung J, Burdowski J, Marfatia R, Bi X, Craft J, Umairi RA, Kindi FA, Williams JL, Campbell MJ, Kharabish A, Gutierrez M, Arzanauskaite M, Ntouskou M, Ashwath ML, Robinson T, Chiang JB, Lee JCY, Lee MSH, Chen SSM. Society for Cardiovascular Magnetic Resonance 2020 Case of the Week series. J Cardiovasc Magn Reson. 2021 10 11; 23(1):108.
Score: 0.007
-
Ames E, Campbell MJ, Afify A, Krane JF, Huang EC. Sclerosing mucoepidermoid carcinoma with eosinophilia: Cytologic characterization of a rare distinct entity in the thyroid. Diagn Cytopathol. 2018 Jul; 46(7):632-635.
Score: 0.005
-
Nixon IJ, Wang LY, Migliacci JC, Eskander A, Campbell MJ, Aniss A, Morris L, Vaisman F, Corbo R, Momesso D, Vaisman M, Carvalho A, Learoyd D, Leslie WD, Nason RW, Kuk D, Wreesmann V, Morris L, Palmer FL, Ganly I, Patel SG, Singh B, Tuttle RM, Shaha AR, G?nen M, Pathak KA, Shen WT, Sywak M, Kowalski L, Freeman J, Perrier N, Shah JP. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer. Thyroid. 2016 Mar; 26(3):373-80.
Score: 0.004
-
Ganly I, Nixon IJ, Wang LY, Palmer FL, Migliacci JC, Aniss A, Sywak M, Eskander AE, Freeman JL, Campbell MJ, Shen WT, Vaisman F, Momesso D, Corbo R, Vaisman M, Shaha A, Tuttle RM, Shah JP, Patel SG. Survival from Differentiated Thyroid Cancer: What Has Age Got to Do with It? Thyroid. 2015 Oct; 25(10):1106-14.
Score: 0.004
-
Gao F, Earnest A, Matchar DB, Campbell MJ, Machin D. Sample size calculations for the design of cluster randomized trials: A summary of methodology. Contemp Clin Trials. 2015 May; 42:41-50.
Score: 0.004
-
Margossian R, Chen S, Sleeper LA, Tani LY, Shirali G, Golding F, Selamet Tierney ES, Altmann K, Campbell MJ, Szwast A, Sharkey A, Radojewski E, Colan SD. The reproducibility and absolute values of echocardiographic measurements of left ventricular size and function in children are algorithm dependent. J Am Soc Echocardiogr. 2015 May; 28(5):549-558.e1.
Score: 0.004